Product Description: Lacutamab (IPH4102) is a humanizedized monoclonal antibody (mAb) directed against the immune receptor molecule KIR3DL2, produced by recombinant technology in CHO cells. Lacutamab can be used in research of cutaneous T-cell lymphoma[1].
Applications: Cancer-programmed cell death
Formula: N/A
References: [1]Van Der Weyden C, et, al. IPH4102, a monoclonal antibody directed against the immune receptor molecule KIR3DL2, for the treatment of cutaneous T-cell lymphoma. Expert Opin Investig Drugs. 2018 Aug;27(8):691-697.
CAS Number: 2187368-16-5
Molecular Weight: N/A
Compound Purity: 99.00
Research Area: Cancer
Solubility: 10 mM in DMSO
Target: Others